Dow 20,000 before the close turn black! Medical biotechnology, energy stocks weak
Donald Trump win the honeymoon market gradually calmed down, with the Dow Jones industrial average nearly in front of 20,000 feelings scared, by weakening health-biotech stocks leading today, 3rd down in the past six sessions. Dow Jones industrial average fell December 21 finale 0.16% (32.66 points), subject to 19,941.96. NASDAQ index fell 0.23% (12.15), subject to 5,471.43. Standard and poor's 500 index fell 0.25% (5.58), subject to 2,265.18.
The Philadelphia semiconductor index rose 0.04% (0.35), 918.33 points, since September 22, 2000 closing high. Trump November 8 election as United States President, the Dow Jones industrial average has surged about 9%. MarketWatch reported, according to FactSet data, SPDR Dow Jones Industrial Average ETF Trust, known as DIA.
US $1.04 billion in the past month, swelling the total assets to $14.8 billion, November sales month 48% to $83 million. However, some analysts worry, Trump won the honeymoon market may be starting to cool, the market is now concerned whether Trump economics works.
Bullish Dow Jones is expected to be before breaking through 20,000 points by the end of the famous Wharton School Finance Professor Jeremy Siegel said in a media interview acknowledged that Wall Street no longer cheap. Best represents the biotech industry the NASDAQ Biotechnology Index, referred to as NBI, down 21st 1.22%, 2,798.01 points since December 7 closing low.
Since Donald Trump at the Time issued on December 7, "cover story" claimed in the interview, unpleasant, and the current state of drug price after trying to drive down drug prices, biotech stocks took a sideways jolt. Merck & Co., Inc., Pfizer Inc. down 1.77% and 1.37%, respectively, up separate Dow Jones 30 components first to second place.
The health care sector of the standard and poor's 500 index fell 0.6%. Sarepta Therapeutics Inc of Biologics company. over the past three months has tumbled almost 50%, physicians will use its drugs for Qiu Xin's muscular dystrophy, and health care providers are willing to put the drug into the scope of payment, are problems that investors worried. Barron's.com 21st, Leerink analyst Joseph Schwartz pointed out that after further investigation, when you publish new Sarepta in early January next year, will let investors disappointed, the stock's current stock prices reasonably reflect the value.
Sarepta continued falling, collecting $29.49 0.51%, a record closing low since September 16. Prices for United States crude inventories rose more than expected and the feet also depressing energy stocks. The New York Mercantile Exchange (NYMEX) 21st February crude futures end down 1.5%, collecting $52.49, ending three consecutive sessions of gains.
United States independent oil and gas exploration giant, Pioneer Natural Resources, oil and gas manufacturer Denbury Resources Inc. small-0.45%, 1.79%, respectively. Stock news, supply of micro electro mechanical systems MEMS gyroscope for consumer electronics manufacturers should be InvenSense, Inc. 21st press release announced that the Japan electronic parts maker TDK Corp. will spend 1.3 billion dollars, at $13 per share price for acquisitions. This confirmed previous rumors in the market.
Legg then gone wild 17.62%, receiving $12.75, a record closing high since August 4, 2015. Investor sentiment remained stable. Chicago Board Options Exchange (CBOE) panic used to measure market volatility index (VIX) 21st fell 1.57%, or 11.27 points, fell for a 5th straight trading day, as most long decline since October. Low VIX is now the peak on November 4 near 50%, about to hit lowest since July 2014.
Like This Post? Please share!
0 意見:
Post a Comment